Week in Review

President Trump delays TikTok ban enforcement, a federal court upholds order blocking Federal Reserve Board member’s firing, and more…

IN THE NEWS

  • President Donald J. Trump issued an executive order delaying the enforcement of the nationwide ban on TikTok, a short-form video and social networking app, until mid-December. This order—President Trump’s fourth time extending the enforcement date of the TikTok ban—follows Treasury Secretary Scott Bessent’s announcement that the United States and China have reached a “framework” for a potential deal on the ownership of TikTok. In the executive order, President Trump delegated the exclusive authority for implementing the TikTok ban to the Attorney General, effectively preventing states from taking independent action on the ban.
  • The U.S. Court of Appeals for the D.C. Circuit upheld a lower court order blocking President Trump’s firing of Federal Reserve Board member Lisa Cook. In a 2-1 decision, the court held that Cook was likely to succeed on her procedural claim that her removal violated the Fifth Amendment’s Due Process Clause. The majority did not address the question of whether the allegations of mortgage fraud against Cook satisfied the “for cause” removal standard for Federal Reserve Board members. In his dissent, Judge Gregory Katsas found that President Trump’s reason for firing Cook met the “for cause” removal standard, which he defined as “some cause relating to the conduct, ability, fitness, or competence of the officer.” The Trump Administration requested that the Supreme Court review this decision.
  • The U.S. District Court for the Northern District of California ruled that the U.S. Office of Personal Management (OPM) lacked the authority to direct other agencies to terminate their probationary, or newly hired, employees. Judge William Alsup reasoned that the terminations violated the Administrative Procedure Act because OPM unlawfully exceeded its own powers, usurped powers reserved by Congress to each individual agency, and was arbitrary and capricious. Rather than reinstate the terminated employees, the court noted they had “moved on with their lives and found new jobs,” and instead ordered updates to their personnel files clarifying they were not fired for performance reasons.
  • The U.S. Department of Health and Human Services appointed five members to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, following the dismissal of all 17 members in June. The appointees, including pediatric cardiologist Kirk Milhoan and epidemiologist Catherine Stein, bring expertise in infectious diseases and maternal health but have histories of criticizing COVID-19 vaccines and pandemic responses. Supporters praised the selections for restoring public trust through diverse perspectives, while critics warned they could undermine evidence-based immunization policies. The committee meets this week to recommend updates on COVID-19 booster shots and hepatitis B and measles vaccines, potentially influencing insurer coverage and public health strategies. The panel recently advised against the MMRV vaccine for young children, citing safety concerns, which raised further debate over their regulatory approach.
  • The U.S. Food and Drug Administration (FDA) issued warning letters to Eli Lilly, Novo Nordisk, and Hims & Hers Health for allegedly misleading communications about weight-loss drugs such as Zepbound, Mounjaro, Wegovy, and Ozempic. The letters, prompted by President Trump’s executive order aimed at enhancing transparency in direct-to-consumer advertising, cited omissions of serious risks such as thyroid tumors and pancreatitis, as well as unapproved compounded semaglutide claims. Supporters, including FDA Commissioner Marty Makary, praised the letters for promoting balanced risk disclosures and protecting consumers from misleading impressions. Critics, including company spokespeople, argued that the cited media interviews were not company-controlled advertisements.
  • President Trump urged the U.S. Securities and Exchange Commission (SEC) in a post on Truth Social to change reporting requirements for public companies from a quarterly to a six-month reporting period. President Trump suggested that the change would save money while allowing managers to focus on “properly running their companies.” SEC Chairman Paul Atkins is reportedly prioritizing this proposal to “further reduce unnecessary regulatory burdens on companies.”
  • FDA cleared a new hypertension detection feature for the Apple Watch Series 11, enabling passive monitoring of the risk of high blood pressure using the device’s optical heart sensor. The algorithm analyzes pulse waves over 30 days to identify patterns indicating hypertension, with a clinical study of over 2,000 participants showing over 92 percent specificity and strong sensitivity for severe cases. Experts praised the clearance for advancing wearable health tools and empowering early detection of serious risks, potentially alerting 1 million undiagnosed users annually. The feature, which requires confirmation by a traditional blood pressure cuff, launches next week in over 150 countries.
  • The State Administration for Market Regulation, China’s primary antitrust regulator, found that American technology company Nvidia had violated Chinese antitrust law with its 2020 acquisition of Mellanox Technologies. The State Administration previously approved the $6.9 billion acquisition on certain conditions. Although the State Administration did not specify a punishment in its one-sentence statement, it reportedly announced it would carry out a “further investigation.” The Cyberspace Administration of China also reportedly ordered Chinese technology companies, including Alibaba and TikTok’s parent company ByteDance, not to buy Nvidia chips made for the Chinese market.

WHAT WE’RE READING THIS WEEK

EDITOR’S CHOICE